13F-HR/A filed by TYNDALL CAPITAL PARTNERS L P
TYNDALL CAPITAL PARTNERS L P filed this 13F-HR/A for the quarter ended 2024-06-30, filed 2024-11-27, with 1 holding row worth $378,987.
- Accession
- 0001493152-24-047983
- Filer
- CIK 1219314
- Filed
- 2024-11-27
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, amendment of type restatement, 1 entries on the cover page, a total value of $378,987 stated on the cover page (in dollars after the unit check, H1), rows summing to $378,987 with VALUE read as dollars as filed, 13F file number 028-10427. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Cyclerion Therapeutics Inc | 23255M204 | COM | 164,777 | $378,987 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-24-032156 | superseded | 2024-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001493152-24-047983 | this filing | 2024-11-27 | acceptance time not in the bulk data set |